Talita Giacomet de Carvalho

Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I

Shunji Tomatsu, Adriana M. Montaño, Toshihiro Oguma et al. · Journal of Inherited Metabolic Disease · 2010 · 73 citations

Life Sciences, Biochemistry, Molecular Biology +8

Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography–tandem mass spectrometry

Shunji Tomatsu, Adriana M. Montaño, Toshihiro Oguma et al. · Journal of Inherited Metabolic Disease · 2010 · 66 citations

Pharmacy, Biochemistry, Chromatographic Analysis +10

Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice

Guilherme Baldo, Fabiana Quoos Mayer, Barbara Martinelli et al. · Molecular Genetics and Metabolism · 2013 · 59 citations · Full text

Life Sciences, Biochemistry, Pathobiology +5

Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers

Roselena Silvestri Schuh, Talita Giacomet de Carvalho, Roberto Giugliani et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2017 · 44 citations

Life Sciences, Biotechnology, Genetics +17

Laronidase-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Promising Formulation for a More Effective Treatment of Mucopolysaccharidosis Type I

Fabiana Quoos Mayer, Márcia Duarte Adorne, Eduardo André Bender et al. · Pharmaceutical Research · 2014 · 41 citations

Pharmacy, Biochemistry, Pharmaceutics +10